🌕 桂花香,月儿圆~
Gate 广场 · 中秋创作激励限时开启!
创作点亮中秋,带上热门话题发帖,就有机会瓜分 $5,000 中秋好礼! 🎁
立即报名参与 👉 https://www.gate.com/campaigns/1953
💡 参与攻略
1️⃣ 在广场发帖并带上话题 #Gate广场创作点亮中秋#
2️⃣ 内容需围绕广场官号(Gate广场_Official)每日发布的热点话题进行创作,并确保带上该热点话题及 #Gate广场创作点亮中秋# 标签
3️⃣ 发帖数量越多,内容越优质,互动量越高,奖励越丰厚!
💰 创作者专属奖励
🏆 Top 1:宝格丽中秋限定礼盒 + $100 合约体验券 + $100 GT
🥈 Top 2:宝格丽中秋限定礼盒 + $80 合约体验券 + $60 GT
🥉 Top 3:宝格丽中秋限定礼盒 + $60 合约体验券 + $30 GT
Top 4-10:宝格丽中秋限定礼盒 + $50 合约体验券
Top 11-20:多功能充电器 + $30 合约体验券
幸运奖(30 位):每人 $20 合约体验券
除此之外每位获奖者都将获得相应的社区流量扶持,增加您的社区影响力!
🍀 新用户特别福利:
第一次在活动期间发帖?恭喜你,还有机会冲击 $600 中秋赏月奖池!
完成任务(完善资料+关注5人+点赞/评论/转发5帖+带话题发首帖),30 位幸运用
SEC Delays Franklin's Solana ETF Decision to November 2025
Key Points:* SEC delays Franklin’s Solana ETF review from September to November 2025.
This delay reflects regulatory caution, impacting Solana’s market dynamics and institutional investment strategies, pending clearer guidance and potential SEC approval outcomes.
SEC Extends Solana ETF Review to November 2025
The SEC has extended its review period for Franklin Templeton’s Solana spot ETF application, originally due on September 15, now to be decided by November 14, 2025. This aligns with broader regulatory caution affecting various crypto ETFs.
Institutional capital allocations remain uncertain, deferring potential inflows into Solana and related products. Market observers note that the regulatory delay affects price speculation, and immediate capital rotations are stalled until a final decision emerges.
Market Awaits SEC Decision Amid Institutional Uncertainty
Did you know? Since 2018, all major altcoin ETF proposals have encountered multi-month delays, mirroring the current pushback with Solana as the SEC navigates evolving regulatory landscapes.
CoinMarketCap data reveals that Solana’s price stands at $223.13, with a market cap of $121.01 billion and dominating 3.05% of the market. Recent 24-hour volume surged by 21.06% to $8.80 billion as Solana experienced a 2.02% price jump, while its 90-day rally neared 55.10%.
| | | --- | | DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |